杨崇双,刘平平,黄学全,肖云华,刘鹤男,李良山,李廷源.125I粒子抑制肝癌移植瘤血管形成的实验研究[J].中华放射医学与防护杂志,2021,41(11):808-812
125I粒子抑制肝癌移植瘤血管形成的实验研究
Experimental study of 125I seeds inhibiting angiogenesis of transplanted hepatocellular carcinoma
投稿时间:2021-05-08  
DOI:10.3760/cma.j.issn.0254-5098.2021.11.002
中文关键词:  肝细胞癌  125I粒子  血管内皮生长因子-A  缺氧诱导因子-1α
英文关键词:Hepatocellular carcinoma  125I seeds  VEGF-A  HIF-1α
基金项目:重庆市社会事业与民生保障科技创新专项(cstc-2016shms-ztzx0045)
作者单位E-mail
杨崇双 陆军军医大学第一附属医院核医学科, 重庆 400038  
刘平平 陆军军医大学第一附属医院核医学科, 重庆 400038  
黄学全 陆军军医大学第一附属医院核医学科, 重庆 400038 hxuequan@163.com 
肖云华 陆军军医大学第一附属医院核医学科, 重庆 400038  
刘鹤男 陆军军医大学第一附属医院核医学科, 重庆 400038  
李良山 陆军军医大学第一附属医院核医学科, 重庆 400038  
李廷源 陆军军医大学第一附属医院核医学科, 重庆 400038  
摘要点击次数: 1788
全文下载次数: 612
中文摘要:
      目的 探讨放射性125I粒子对肝癌裸鼠皮下移植瘤微血管形成的影响及其机制。方法 构建人肝癌Huh7细胞裸鼠皮下移植瘤模型,将12只裸鼠用随机数表法分为观察组和对照组,每组6只。观察组移植瘤植入一枚活度为2.96×107Bq粒子,对照组植入一枚活度为0的空粒子。每4天测量1次移植瘤体积,记录肿瘤生长曲线。28 d后取下移植瘤,用免疫组织化学染色法检测CD31评估移植瘤微血管密度(MVD)。用免疫组织化学染色法检测血管内皮生长因子-A(VEGF-A)、缺氧诱导因子1α(HIF-1α)蛋白表达,并做半定量分析。用实时荧光定量聚合酶链反应(RT-PCR)检测VEGF-A、HIF-1α mRNA的表达。结果 观察组移植瘤的生长速度较对照组缓慢,粒子植入后12 d两组肿瘤体积差异有统计学意义(t=3.167,P<0.05),随着观察时间延长,两组肿瘤体积差距加大,在28 d时两组肿瘤体积分别为(963.61±89.56)mm3和(602.10±75.98)mm3t=7.122,P<0.05)。两组移植瘤组织中CD31均有表达,观察组的MVD较对照组少,差异有统计学意义(t=6.360,P<0.05)。观察组VEGF-A、HIF-1α mRNA及蛋白的表达水平均低于对照组,差异均有统计学意义(t=10.480、6.414、10.890、12.250,P<0.05)。结论 放射性125I粒子通过降低肿瘤微血管密度抑制肝癌移植瘤的生长,其机制可能与VEGF-A、HIF-1α的mRNA及蛋白表达减少有关。
英文摘要:
      Objective To investigate the effect of radioactive 125I seed on angiogenesis of subcutaneously transplanted hepatocellular carcinoma in nude mice and underlying mechanism. Methods The subcutaneous transplanted tumor model of human hepatocellular carcinoma Huh7 cells was established in nude mice. Twelve nude mice were randomly divided into observation group and control group with 6 mice in each group. The 125I seed with activity of 2.96×107 Bq was implanted into the transplanted tumor of observation group and another with 0 Bq as control group, respectively. The volume of the transplanted tumor was measured every 4 d and the growth curve of the tumor was recorded. The microvessel density (MVD) of the transplanted tumor was evaluated by immunohistochemical detection of CD31. VEGF-A and HIF-1α protein and mRNA were detected by immunohistochemistry and RT-PCR, respectively. Results The growth rate of tumor in the observation group was slower than that in the control group, and the difference of tumor volume between two groups at 12 d after 125I seed implantation was significantly different(t=3.167, P<0.05). At 28 d after transplantation, the tumor volumes of control and observation group approached to (963.61 ±89.56) mm3 and (602.10±75.98) mm3, respectively. The MVD of the observation group was significantly lower than that of the control group (t=6.361, P<0.05). The relative expression of VEGF-A and HIF-1α mRNA in the observation group was significantly lower than that in the control group (t=10.480, 6.414, P<0.05). Protein expression levels of VEGF-A and HIF-1α in the observation group were lower than those in the control group (t=10.890, 12.250, P<0.05). Conclusions Radioactive 125I seed can inhibit the growth of HCC xenografts by reducing tumor microvessels, which may be related to the decrease of VEGF-A and HIF-1α expression.
HTML  查看全文  查看/发表评论  下载PDF阅读器
关闭